NCT00015860View on ClinicalTrials.gov

STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2001

Study Completion Date

October 31, 2003

Conditions
Leukemia
Interventions
DRUG

daunorubicin hydrochloride

DRUG

imatinib mesylate

DRUG

prednisone

DRUG

vincristine sulfate

Trial Locations (5)

90095

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

91010

City of Hope Comprehensive Cancer Center, Duarte

97239

Oregon Cancer Institute, Portland

94305-5408

Stanford University Medical Center, Stanford

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00015860 - STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter